Read the latest epilepsy news from Epilepsy Society.
What do you think of public transport for disabled people?
16 November 2017
The Department of Transport wants to hear from people with epilepsy and other disabilities about their experiences of travelling on public transport.
Changes to PIP set to benefit people with epilepsy
3 November 2017
People with epilepsy could benefit from new guidelines announced by the Government this week, for assessing those who receive PIP - the Personal Independence Payment...
Standing ovation as Epilepsy Society's professor wins Excellence in Epilepsy Award
31 October 2017
A standing ovation as Epilepsy Society's Professor Philip Patsalos is awarded the 2016 Excellence in Epilepsy Award by the British Chapter of the International League...
MPs debate safety issues around sodium valproate in House of Commons
19 October 2017
Although we could not see them as we watched today's sodium valproate debate via Parliament Live TV, the presence of three women -Janet Williams, Emma Murphy and...
Health secretary Jeremy Hunt sends second letter to Epilepsy Society
19 October 2017
Epilepsy Society's chief executive, Clare Pelham, has welcomed a second letter from the Department of Health in response to her letter to health secretary Jeremy Hunt...
Arlene Foster and DUP support Epilepsy Society sodium valproate campaign
18 October 2017
Arlene Foster, leader of the Democratic Unionist Party and First Minister of Northern Ireland has pledged her support for Epilepsy Society's campaign to ensure...
Jeremy Hunt responds to Epilepsy Society on sodium valproate
17 October 2017
Epilepsy Society's chief executive, Clare Pelham, receives a response from health secretry Jeremy Hunt about safety issues around epilepsy drug, sodium valproate.
MPs debate sodium valproate in House of Commons
16 October 2017
This Thursday (19 October 2017), MPs will be meeting in the House of Commons to debate safety issues around the epilepsy drug sodium valproate.
Sodium valproate public hearing - summary report
9 October 2017
Following last month's public hearing into the epilepsy drug sodium valproate, the European Medicines Agency(EMA) has now published a full summary report.
Problem with supplies of Teva lamotrigine
6 October 2017
Teva lamotrigine dispersible drugs are currently unavailable in 5mg, 25mg and 100mg strengths. This is due to problems with the manufacture of the drug.